Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Dow
Colorcon
Mallinckrodt
Johnson and Johnson

Last Updated: May 24, 2022

DSUVIA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Dsuvia, and what generic alternatives are available?

Dsuvia is a drug marketed by Acelrx Pharms and is included in one NDA. There are eighteen patents protecting this drug.

This drug has ninety-two patent family members in nineteen countries.

The generic ingredient in DSUVIA is sufentanil citrate. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.

Summary for DSUVIA
Drug patent expirations by year for DSUVIA
Drug Prices for DSUVIA

See drug prices for DSUVIA

Recent Clinical Trials for DSUVIA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
United States Department of DefensePhase 3
Frank GuyettePhase 3
Montefiore Medical CenterPhase 4

See all DSUVIA clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for DSUVIA

US Patents and Regulatory Information for DSUVIA

DSUVIA is protected by eighteen US patents.

Patents protecting DSUVIA

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Small-volume oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Small-volume oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Small-volume oral transmucosal dosage
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Small-volume oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN

Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acelrx Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128-001 Nov 2, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Acelrx Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128-001 Nov 2, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Acelrx Pharms DSUVIA sufentanil citrate TABLET;SUBLINGUAL 209128-001 Nov 2, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for DSUVIA

See the table below for patents covering DSUVIA around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 2008085765 See Plans and Pricing
European Patent Office 2808005 Dispositifs de stockage et de distribution destinés à l'administration de formes pharmaceutiques transmucosiques orales (Storage and dispensing devices for administration of oral transmucosal dosage forms) See Plans and Pricing
Portugal 2367537 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for DSUVIA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2114383 SPC/GB16/004 United Kingdom See Plans and Pricing PRODUCT NAME: SUFENTANIL; REGISTERED: UK EU/1/15/1042 20150922
2114383 CA 2016 00007 Denmark See Plans and Pricing PRODUCT NAME: SUFENTANIL, HERUNDER SUFENTANIL SOM CITRAT; REG. NO/DATE: EU/1/15/1042/001-006 20150922
2114383 122016000023 Germany See Plans and Pricing PRODUCT NAME: SUFENTANIL, WAHLWEISE IN FORM VON SUFENTANILCITRAT; REGISTRATION NO/DATE: EU/1/15/1042 20150918
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Harvard Business School
McKesson
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.